BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16369215)

  • 1. Role of liver biopsy in the management of chronic liver disease: selective rather than routine.
    Reiss G; Keeffe EB
    Rev Gastroenterol Disord; 2005; 5(4):195-205. PubMed ID: 16369215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus genotype 3 predominates in North and Central India and is associated with significant histopathologic liver disease.
    Hissar SS; Goyal A; Kumar M; Pandey C; Suneetha PV; Sood A; Midha V; Sakhuja P; Malhotra V; Sarin SK
    J Med Virol; 2006 Apr; 78(4):452-8. PubMed ID: 16482560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    Goodman ZD
    J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities.
    Sorbi D; McGill DB; Thistle JL; Therneau TM; Henry J; Lindor KD
    Am J Gastroenterol; 2000 Nov; 95(11):3206-10. PubMed ID: 11095343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic evaluation of nonalcoholic fatty liver disease.
    Adams LA; Talwalkar JA
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S34-8. PubMed ID: 16540765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FibroMAX: towards a new universal biomarker of liver disease?
    Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
    Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of liver histology in diagnosis of chronic hepatopathies].
    Schmid M
    Praxis (Bern 1994); 1998 Oct; 87(42):1397-401. PubMed ID: 9824946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive tools to assess liver disease.
    Patel K
    Curr Opin Gastroenterol; 2010 May; 26(3):227-33. PubMed ID: 20179592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
    Heidelbaugh JJ; Bruderly M
    Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients.
    Weigand K; Weigand K
    J Gastroenterol Hepatol; 2009 May; 24(5):792-9. PubMed ID: 19220661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
    Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the natural history of chronic hepatitis B in the era of transient elastography.
    Chan HL; Wong GL; Wong VW
    Antivir Ther; 2009; 14(4):489-99. PubMed ID: 19578234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential findings for CD14-positive hepatic monocytes/macrophages in primary biliary cirrhosis, chronic hepatitis C and nonalcoholic steatohepatitis.
    Leicester KL; Olynyk JK; Brunt EM; Britton RS; Bacon BR
    Liver Int; 2006 Jun; 26(5):559-65. PubMed ID: 16762000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of liver biopsy in the diagnosis of autoimmune hepatitis].
    Szabó Z
    Orv Hetil; 2006 Sep; 147(35):1697-702. PubMed ID: 17051746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.